Journal of dermatological science最新文献

筛选
英文 中文
Low-dose imiquimod induces melanogenesis in melanoma cells through an ROS-mediated pathway 低剂量咪喹莫特通过 ROS 介导的途径诱导黑色素瘤细胞的黑色素生成
IF 4.6 3区 医学
Journal of dermatological science Pub Date : 2023-12-22 DOI: 10.1016/j.jdermsci.2023.12.005
Zheng-Yi Li, Shu-Hao Chang, Kuang-Ting Liu, Alaina Edelie Wu, Chien-Sheng Hsu, Shi-Wei Huang, Mu-Chi Chung, Shih-Chung Wang, Jun-Kai Kao, Yi-Ju Chen, Jeng-Jer Shieh
{"title":"Low-dose imiquimod induces melanogenesis in melanoma cells through an ROS-mediated pathway","authors":"Zheng-Yi Li, Shu-Hao Chang, Kuang-Ting Liu, Alaina Edelie Wu, Chien-Sheng Hsu, Shi-Wei Huang, Mu-Chi Chung, Shih-Chung Wang, Jun-Kai Kao, Yi-Ju Chen, Jeng-Jer Shieh","doi":"10.1016/j.jdermsci.2023.12.005","DOIUrl":"https://doi.org/10.1016/j.jdermsci.2023.12.005","url":null,"abstract":"<h3>Background</h3><p>Melanogenesis is the process of melanin maturation which not only protects skin from UV radiation but also plays an important role in antigenicity of melanomas. Imiquimod (IMQ) is a toll-like receptor 7 (TLR7) agonist that exhibits antiviral and anticancer activity.</p><h3>Objective</h3><p>To explore whether IMQ could induce melanogenesis in melanoma cells.</p><h3>Methods</h3><p>The mouse melanoma cell line B16F10, the mouse immortalized melanocyte Melan-A, and human melanoma cell lines MNT-1, C32 and A375 were utilized in this study. The pigmented level was observed by the centrifuged cell pellet. The intracellular and extracellular melanin levels were examined in the absorbance in NaOH-extracted cell lysate and cell-cultured medium, respectively. The expression of melanogenesis related proteins was examined by immunoblotting. The intracellular cyclic AMP amount was evaluated by the cAMP Glo assay kit. The activity of phosphodiesterase 4B (PDE4B) was investigated by CREB reporter assay with overexpressed PDE4B or not.</p><h3>Results</h3><p>We demonstrated that a low dose of IMQ could trigger melanogenesis in B16F10 cells. IMQ induced microphthalmia-associated transcription factor (MITF) nuclear translocation, upregulated the expression of melanogenesis-related proteins, increased tyrosinase (TYR) activity, and led to pigmentation in B16F10 cells. Next, we found that IMQ-induced melanogenesis was activated by excessive intracellular cAMP accumulation, which was regulated through IMQ-mediated PDE4B inhibition. Finally, IMQ-induced ROS production was found to be involved in melanogenesis by its control of PDE4B activity.</p><h3>Conclusions</h3><p>Low dose of IMQ could activate melanogenesis through the ROS/PDE4B/PKA pathway in melanoma cells.</p>","PeriodicalId":15641,"journal":{"name":"Journal of dermatological science","volume":null,"pages":null},"PeriodicalIF":4.6,"publicationDate":"2023-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139031360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Contribution to the peripheral vasculopathy and endothelial cell dysfunction by CXCL4 in Systemic Sclerosis. 在系统性硬化症中,CXCL4对周围血管病变和内皮细胞功能障碍的贡献。
IF 4.6 3区 医学
Journal of dermatological science Pub Date : 2020-07-13 DOI: 10.21203/rs.3.rs-41064/v1
Zhixing Jiang, Chen Chen, Sen Yang, Hang He, Xiaoxia Zhu, Minrui Liang
{"title":"Contribution to the peripheral vasculopathy and endothelial cell dysfunction by CXCL4 in Systemic Sclerosis.","authors":"Zhixing Jiang, Chen Chen, Sen Yang, Hang He, Xiaoxia Zhu, Minrui Liang","doi":"10.21203/rs.3.rs-41064/v1","DOIUrl":"https://doi.org/10.21203/rs.3.rs-41064/v1","url":null,"abstract":"BACKGROUND\u0000CXCL4, a chemokine with anti-angiogenic property, is involved in systemic sclerosis (SSc) related pulmonary arterial hypertension (PAH).\u0000\u0000\u0000OBJECTIVE\u0000To investigated the contribution of CXCL4 to SSc development by focusing on the correlation of circulatory CXCL4 levels with their peripheral vasculopathy, and the effect of CXCL4 on endothelial cell dysfunction and the potential signaling.\u0000\u0000\u0000METHODS\u0000We measured the plasma CXCL4 levels in 58 patients with SSc, 10 patients with the very early diagnosis of SSc (VEDOSS), and 80 healthy controls (HCs). Then, CXCL4 concentrations were correlated with clinical features, especially the peripheral vasculopathy. These observations were further validated in an additional cohort. Moreover, we studied the anti-angiogenic effects of CXCL4 and the underlying downstream signaling in human umbilical vein endothelial cells (HUVECs) in vitro.\u0000\u0000\u0000RESULTS\u0000Circulating CXCL4 levels were 103.62 % higher in patients with SSc and 201.51 % higher in patients with VEDOSS than matched HCs, which were confirmed in two independent cohorts. CXCL4 levels were associated with digital ulcers (DU) and nailfold videocapillaroscopy (NVC) abnormalities in SSc. The proliferation, migration, and tube formation of HUVECs were inhibited by CXCL4 or SSc derived plasma, which reversed by CXCL4 neutralizing antibody, but failed by CXCR3 inhibitor. CXCL4 downregulated the transcription factor Friend leukaemia integration factor-1 (Fli-1) via c-Abl signaling. Furthermore, CXCL4 blocked the transforming growth factor (TGF) -β or platelet-derived growth factor (PDGF) induced cell proliferation of HUVECs.\u0000\u0000\u0000CONCLUSIONS\u0000CXCL4 may contribute to peripheral vasculopathy in SSc by downregulating Fli-1 via c-Abl signaling in endothelial cells and interfering angiogenesis.","PeriodicalId":15641,"journal":{"name":"Journal of dermatological science","volume":null,"pages":null},"PeriodicalIF":4.6,"publicationDate":"2020-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85463837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Chronic infection with the protozoan Toxoplasma gondii prevents the development of experimental atopic dermatitis in mice. 弓形虫原生动物慢性感染可预防小鼠实验性特应性皮炎的发生。
IF 4.6 3区 医学
Journal of dermatological science Pub Date : 2019-11-02 DOI: 10.1016/j.jdermsci.2019.10.007
Matías Perrone Sibilia, María de Los Angeles Aldirico, A. Soto, M. S. Picchio, Vanesa R. Sánchez, Nadia Arcon, R. Moretta, V. Martín, S. Vanzulli, I. Fenoy, A. Goldman
{"title":"Chronic infection with the protozoan Toxoplasma gondii prevents the development of experimental atopic dermatitis in mice.","authors":"Matías Perrone Sibilia, María de Los Angeles Aldirico, A. Soto, M. S. Picchio, Vanesa R. Sánchez, Nadia Arcon, R. Moretta, V. Martín, S. Vanzulli, I. Fenoy, A. Goldman","doi":"10.1016/j.jdermsci.2019.10.007","DOIUrl":"https://doi.org/10.1016/j.jdermsci.2019.10.007","url":null,"abstract":"","PeriodicalId":15641,"journal":{"name":"Journal of dermatological science","volume":null,"pages":null},"PeriodicalIF":4.6,"publicationDate":"2019-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73198277","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Possible therapeutic applicability of galectin-9 in cutaneous T-cell lymphoma. 半凝集素-9在皮肤t细胞淋巴瘤中可能的治疗适用性。
IF 4.6 3区 医学
Journal of dermatological science Pub Date : 2019-09-16 DOI: 10.1016/j.jdermsci.2019.09.004
R. Nakajima, T. Miyagaki, H. Kamijo, T. Oka, Naomi Shishido-Takahashi, H. Suga, M. Sugaya, S. Sato
{"title":"Possible therapeutic applicability of galectin-9 in cutaneous T-cell lymphoma.","authors":"R. Nakajima, T. Miyagaki, H. Kamijo, T. Oka, Naomi Shishido-Takahashi, H. Suga, M. Sugaya, S. Sato","doi":"10.1016/j.jdermsci.2019.09.004","DOIUrl":"https://doi.org/10.1016/j.jdermsci.2019.09.004","url":null,"abstract":"","PeriodicalId":15641,"journal":{"name":"Journal of dermatological science","volume":null,"pages":null},"PeriodicalIF":4.6,"publicationDate":"2019-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80574037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 15
Apremilast mechanism of efficacy in systemic-naive patients with moderate plaque psoriasis: Pharmacodynamic results from the UNVEIL study. 阿普雷米司特治疗中度斑块型银屑病的机制:揭幕研究的药效学结果。
IF 4.6 3区 医学
Journal of dermatological science Pub Date : 2019-09-10 DOI: 10.1016/j.jdermsci.2019.09.003
B. Strober, A. Alikhan, B. Lockshin, Rebecca Shi, J. Cirulli, P. Schafer
{"title":"Apremilast mechanism of efficacy in systemic-naive patients with moderate plaque psoriasis: Pharmacodynamic results from the UNVEIL study.","authors":"B. Strober, A. Alikhan, B. Lockshin, Rebecca Shi, J. Cirulli, P. Schafer","doi":"10.1016/j.jdermsci.2019.09.003","DOIUrl":"https://doi.org/10.1016/j.jdermsci.2019.09.003","url":null,"abstract":"","PeriodicalId":15641,"journal":{"name":"Journal of dermatological science","volume":null,"pages":null},"PeriodicalIF":4.6,"publicationDate":"2019-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77360070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Meeting Report: Japan – Singapore International Skin Conference, Singapore April 10-12, 2019 会议报告:日本-新加坡国际皮肤会议,新加坡,2019年4月10日至12日
IF 4.6 3区 医学
Journal of dermatological science Pub Date : 2019-05-01 DOI: 10.1016/j.jdermsci.2019.05.006
{"title":"Meeting Report: Japan – Singapore International Skin Conference, Singapore April 10-12, 2019","authors":"","doi":"10.1016/j.jdermsci.2019.05.006","DOIUrl":"https://doi.org/10.1016/j.jdermsci.2019.05.006","url":null,"abstract":"","PeriodicalId":15641,"journal":{"name":"Journal of dermatological science","volume":null,"pages":null},"PeriodicalIF":4.6,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73302344","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Obituary: Stephen I. Katz, MD, PhD (1941–2018) 讣告:Stephen I. Katz, MD, PhD (1941-2018)
IF 4.6 3区 医学
Journal of dermatological science Pub Date : 2019-02-01 DOI: 10.1016/s0923-1811(19)30057-x
M. Amagai
{"title":"Obituary: Stephen I. Katz, MD, PhD (1941–2018)","authors":"M. Amagai","doi":"10.1016/s0923-1811(19)30057-x","DOIUrl":"https://doi.org/10.1016/s0923-1811(19)30057-x","url":null,"abstract":"","PeriodicalId":15641,"journal":{"name":"Journal of dermatological science","volume":null,"pages":null},"PeriodicalIF":4.6,"publicationDate":"2019-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74537209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PD-1, TIGIT, and LAG-3 signals synergistically suppress the anti-melanoma CTL response in the effector phase PD-1、TIGIT和LAG-3信号在效应期协同抑制抗黑色素瘤CTL反应
IF 4.6 3区 医学
Journal of dermatological science Pub Date : 2017-05-01 DOI: 10.1016/J.JDERMSCI.2017.02.186
T. Inozume, T. Yaguchi, T. Kawamura, Y. Kawakami, S. Shimada
{"title":"PD-1, TIGIT, and LAG-3 signals synergistically suppress the anti-melanoma CTL response in the effector phase","authors":"T. Inozume, T. Yaguchi, T. Kawamura, Y. Kawakami, S. Shimada","doi":"10.1016/J.JDERMSCI.2017.02.186","DOIUrl":"https://doi.org/10.1016/J.JDERMSCI.2017.02.186","url":null,"abstract":"","PeriodicalId":15641,"journal":{"name":"Journal of dermatological science","volume":null,"pages":null},"PeriodicalIF":4.6,"publicationDate":"2017-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74925490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Disrupted constitution of stratum corneum intercellular lipids contribute to barrier disruption in glycated epidermis 角质层细胞间脂质的破坏导致糖基化表皮的屏障破坏
IF 4.6 3区 医学
Journal of dermatological science Pub Date : 2017-05-01 DOI: 10.1016/J.JDERMSCI.2017.02.134
M. Yokota, H. Masaki, Y. Tokudome
{"title":"Disrupted constitution of stratum corneum intercellular lipids contribute to barrier disruption in glycated epidermis","authors":"M. Yokota, H. Masaki, Y. Tokudome","doi":"10.1016/J.JDERMSCI.2017.02.134","DOIUrl":"https://doi.org/10.1016/J.JDERMSCI.2017.02.134","url":null,"abstract":"","PeriodicalId":15641,"journal":{"name":"Journal of dermatological science","volume":null,"pages":null},"PeriodicalIF":4.6,"publicationDate":"2017-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74414171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ambrisentan moderately, but not significantly, improved impaired wound healing by bleomycin treatment in mice 氨布里森坦适度但不显著地改善了博来霉素治疗小鼠的伤口愈合
IF 4.6 3区 医学
Journal of dermatological science Pub Date : 2017-05-01 DOI: 10.1016/J.JDERMSCI.2017.02.265
M. Ishikawa, Toshiyuki Yamamoto
{"title":"Ambrisentan moderately, but not significantly, improved impaired wound healing by bleomycin treatment in mice","authors":"M. Ishikawa, Toshiyuki Yamamoto","doi":"10.1016/J.JDERMSCI.2017.02.265","DOIUrl":"https://doi.org/10.1016/J.JDERMSCI.2017.02.265","url":null,"abstract":"","PeriodicalId":15641,"journal":{"name":"Journal of dermatological science","volume":null,"pages":null},"PeriodicalIF":4.6,"publicationDate":"2017-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81546889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信